Ovarian granulosa cell tumor: clinical features, treatment, outcome, and prognostic factors
- PMID: 24741552
- PMCID: PMC3978936
- DOI: 10.4103/1947-2714.128475
Ovarian granulosa cell tumor: clinical features, treatment, outcome, and prognostic factors
Abstract
Background: Granulosa cell tumors are rare neoplasms characterized by long natural history and favorable prognosis.
Aims: The objective of this study was to determine the clinical presentation, treatment, outcome, and prognostic factors for patients of granulosa cell tumors.
Materials and methods: A retrospective analysis of 26 patients of granulosa cell tumor of ovary from 2002 to 2011 was carried out. The records of all patients were analyzed to determine clinical presentation, treatment, survival, and prognostic factors.
Results: The median age of the patients was 50 years (range, 17-71 years). Abdominal pain was the most common presenting symptom. The median follow-up was 71.4 months (range, 21.6-149.9 months). The estimated 5 and 10 year overall survival (OS) was 84.6 and 72.5%, respectively. Event-free survival (EFS) was 76.5 and 52.9% at 5 and 10 years, respectively. Advanced stage was significant independent poor prognostic indicator for both OS and EFS.
Conclusion: Majority of the patients with granulosa cell tumors of the ovary present in early stage. Surgery is the primary treatment modality for granulosa cell tumors. Advanced stage and presence of residual disease were associated with inferior survival, but only prospective studies can ascertain their definite role.
Keywords: Granulosa cell tumor; Ovary; Prognosis; Survival; Treatment.
Conflict of interest statement
Figures
Similar articles
-
Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases.J Gynecol Oncol. 2009 Sep;20(3):158-63. doi: 10.3802/jgo.2009.20.3.158. Epub 2009 Sep 30. J Gynecol Oncol. 2009. PMID: 19809549 Free PMC article.
-
Granulosa cell tumor of the ovary: retrospective analysis of 45 cases.Am J Clin Oncol. 2003 Oct;26(5):517-21. doi: 10.1097/01.coc.0000037918.88451.6A. Am J Clin Oncol. 2003. PMID: 14528083
-
Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.Anticancer Res. 2004 Mar-Apr;24(2C):1223-9. Anticancer Res. 2004. PMID: 15154651
-
Recent advances in granulosa cell tumor ovary: a review.Indian J Surg Oncol. 2013 Mar;4(1):37-47. doi: 10.1007/s13193-012-0201-z. Epub 2012 Dec 7. Indian J Surg Oncol. 2013. PMID: 24426698 Free PMC article. Review.
-
Granulosa cell tumor of the ovary: tumor review.Integr Cancer Ther. 2008 Sep;7(3):204-15. doi: 10.1177/1534735408322845. Integr Cancer Ther. 2008. PMID: 18815151 Review.
Cited by
-
Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.Cancer Res. 2020 Sep 1;80(17):3466-3479. doi: 10.1158/0008-5472.CAN-20-0259. Epub 2020 Jul 8. Cancer Res. 2020. PMID: 32641411 Free PMC article.
-
FOXO1 Negates the Cooperative Action of FOXL2C134W and SMAD3 in CYP19 Expression in HGrC1 Cells by Sequestering SMAD3.J Endocr Soc. 2019 Aug 29;3(11):2064-2081. doi: 10.1210/js.2019-00279. eCollection 2019 Nov 1. J Endocr Soc. 2019. PMID: 31701078 Free PMC article.
-
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.Clin Cancer Res. 2020 Aug 15;26(16):4402-4413. doi: 10.1158/1078-0432.CCR-19-1905. Epub 2020 May 14. Clin Cancer Res. 2020. PMID: 32409304 Free PMC article.
-
Adult-Type Ovarian Granulosa Cell Tumour: Treatment Outcomes From a Single-Institution Experience.Cureus. 2022 Nov 3;14(11):e31045. doi: 10.7759/cureus.31045. eCollection 2022 Nov. Cureus. 2022. PMID: 36475202 Free PMC article.
-
Intraoperative Diagnosis: Imprint Cytology and Frozen Section in Ovarian Tumor, Averting Additional Surgery.J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S4185-S4188. doi: 10.4103/jpbs.jpbs_1409_24. Epub 2024 Dec 5. J Pharm Bioallied Sci. 2024. PMID: 39927044 Free PMC article.
References
-
- Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180–9. - PubMed
-
- Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL. Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol. 1978;52:718–23. - PubMed
-
- Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol. 1976;125:402–11. - PubMed
-
- Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Selle B, Sternschulte W, et al. Ovarian sex cord-stromal tumors in children and adolescents. J Clin Oncol. 2003;21:2357–63. - PubMed
-
- Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecol Oncol. 1999;72:131–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources